U.S. OKs new uses for Genentech, Biogen lymphoma drug
297310
U.S. regulators have approved wider use of Genentech Inc. and Biogen Idec Inc.'s drug Rituxan for patients with a type of lymphoma, the companies announced on Friday.
145081
For a small biopharmaceutical firm that has yet to get a drug on the market, Medarex Inc. has been keeping some impressive company. Top pharmaceutical and biotech firms, from Johnson &amp; Johnson to Amgen Inc., have been signing deals with Medarex to use its genetically engineered mice as they seek to develop new drugs. The doctored mice have the rare ability to produce human antibodies, which can help fight disease just as natural antibodies do.
294828
FRIDAY, June 15 (HealthDay News) -- Cancer drugs may be able to switch on a gene that tumor cells have switched off, potentially offering a new target for treatment, scientists say.
44693
Celera Genomics Group of Rockville announced an agreement Tuesday to provide potential targets for cancer drugs to biotech giant Genentech Inc. -The Washington Post
560148
The Food and Drug Administration approved Clolar, Genzyme Corp.&#39;s new drug for patients under 21 with acute lymphocytic leukemia.
255760
Biogen Idec Inc., of Cambridge, had a remarkable 2004. Biogen had just finalized its $6.4 billion merger with Idec Corp., of San Diego, when it got word the Food and Drug Administration would consider its new multiple sclerosis drug on the basis of interim trial data, accelerating the approval timetable by a year. The company scrambled, applied on May 25, ...
289071
Today was a day of good news for multiple sclerosis patients: FDA granted approval to a new anti-multiple sclerosis drug Antegren developed by Biogen Idec Inc.
623395
Biogen Idec Inc. of Cambridge said it is in final discussions with the Food and Drug Administration about its new multiple sclerosis drug Antegren, and expects the drug to be approved by the end of the month.
92836
THURSDAY, Aug. 19 (HealthDayNews) -- A new screening technique to search for genes that change patients' response to cancer drugs and other medications has been developed by scientists at Washington University Medical Center.
131156
LONDON (CBS.MW) -- The US Food and Drug Administration has approved a Genzyme Corp. (GENZ) cancer drug for treating a type of childhood leukemia after other therapies have failed.
554059
A second-line drug to treat a life-threatening form of leukemia has won federal approval, the Food and Drug Administration said Monday.
295886
The U.S. Food and Drug  Administration said on Wednesday it had approved Amgen Inc's  drug Vectibix for the treatment of advanced colon cancer.
510674
NEW YORK, November 19  - Tarceva, an experimental lung cancer drug, has been approved by the Food &amp; Drug Administration, Genentech (DNA.
26798
Early yesterday evening, Biogen IDEC (Nasdaq: BIIB) and Elan (NYSE: ELN) announced that Tysabri had been approved by the FDA for the treatment of multiple sclerosis (MS).
211121
Genentech Inc colon and lung cancer drug Avastin, along with standard chemotherapy, increases survival rates of patients with a very deadly type of brain tumor, U.S. researchers said on Thursday.
494130
Genzyme Corp. announced Wednesday that its drug Clolar has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of children with difficult or relapsed acute lymphoblastic leukemia (ALL).
555063
NEW YORK  - Genzyme Corp. announced Wednesday that its drug Clolar has been approved by the US Food and Drug Administration (news - web sites) (FDA (news - web sites)) for the treatment of